Table 2 The association between denosumab use and breast cancer risk
From: Denosumab and breast cancer risk in postmenopausal women: a population-based cohort study
Strata | BC events | Univariate | ||
|---|---|---|---|---|
No denosumab | Denosumab | HR (95% CI) | P | |
Ever/never denosumab use | 957 | 281 | 0.87 (0.76–1.00) | 0.04 |
Cumulative dose | ||||
Per injection | 0.98 (0.94–1.01) | 0.15a | ||
1–2 injections | - | 124 | 0.82 (0.68–1.00) | 0.04 |
3–4 injections | - | 71 | 0.88 (0.69–1.13) | 0.32 |
5+injections | - | 86 | 0.95 (0.75–1.20) | 0.65 |
